Clinical trial
SJG-136 in Treating Patients With Solid Tumors That Are Metastatic or Cannot Be…
NCT00121290 · National Cancer Institute (NCI), NIH · Completed
Key facts
| NCT number | NCT00121290 |
|---|---|
| Title | SJG-136 in Treating Patients With Solid Tumors That Are Metastatic or Cannot Be Removed By Surgery |
| Official title | A Phase I Dose Escalation Study of Daily x 3 Intravenous SJG-136 in Patients With Advanced Solid Tumors |
| Lead sponsor | National Cancer Institute (NCI), NIH |
| Status | Completed |
| Phase | Phase 1 |
| Study type | Interventional |
| Conditions | Unspecified Adult Solid Tumor, Protocol Specific |
| Intervention type | Drug, Other |
| Interventions | SJG-136, laboratory biomarker analysis, pharmacological study |
| Enrollment | 39 |
| Start date | Feb 1, 2005 |
| Primary completion | Apr 1, 2008 |
| First posted | Jul 21, 2005 |
| Last update posted | Feb 24, 2014 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: